VRTX
Vertex Pharmaceuticals Incorporated
NASDAQ · Healthcare · Biotechnology · US
$546.12
−2.12%Forward multiples
Based on analyst estimates
- P/E forward
- 28.02x
- P/E 2026E
- 29.33x
- P/E 2027E
- 25.81x
- P/E 2028E
- 21.72x
- P/S forward
- 9.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- 31.53x
- PEG TTM
- 2.53x
- Price / book
- 6.84x
- Price / sales
- 10.96x
- Price / cash flow
- 32.24x
Enterprise value
- Enterprise value
- $132.5B
- EV / sales
- 10.50x
- EV / EBITDA
- 24.34x
- EV / EBIT
- 27.21x
- Market cap
- $138.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026